Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2017-01-04

FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved a supplemental labeling change for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC. The supplemental application updates …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Effexor XR (venlafaxine)

Snippet

SUPPL AP for EFFEXOR XR (VENLAFAXINE HYDROCHLORIDE)